Tonnessen-Murray Crystal A, Lozano Guillermina, Jackson James G
Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, Louisiana 70112.
Department of Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas 77030.
Cold Spring Harb Perspect Med. 2017 Feb 1;7(2):a026112. doi: 10.1101/cshperspect.a026112.
Transformed cells have properties that allow them to survive and proliferate inappropriately. These characteristics often arise as a result of mutations caused by DNA damage. p53 suppresses transformation by removing the proliferative or survival capacity of cells with DNA damage or inappropriate cell-cycle progression. Cellular senescence, marked by morphological and gene expression changes, is a critical component of p53-mediated tumor suppression. In response to stress, p53 can facilitate an arrest and senescence program in cells exposed to stresses such as DNA damage and oncogene activation, preventing transformation. Senescent cells are evident in precancerous adenoma-type lesions, whereas proliferating, malignant tumors have bypassed senescence, either by p53 mutation or inactivation of the p53 pathway by other means. Tumors that have retained wild-type p53 often show a p53-mediated senescence response to chemotherapy. This response is actually detrimental in some tumor types, as senescent cells can drive relapse by persisting and producing cytokines and chemokines through an acquired secretory phenotype.
转化细胞具有使其能够异常存活和增殖的特性。这些特征通常是由DNA损伤导致的突变引起的。p53通过消除具有DNA损伤或细胞周期进程异常的细胞的增殖或存活能力来抑制转化。以形态和基因表达变化为特征的细胞衰老,是p53介导的肿瘤抑制的关键组成部分。响应应激时,p53可促进暴露于DNA损伤和癌基因激活等应激的细胞进入停滞和衰老程序,从而防止转化。衰老细胞在癌前腺瘤样病变中很明显,而增殖性恶性肿瘤则通过p53突变或其他方式使p53通路失活而绕过了衰老过程。保留野生型p53的肿瘤通常对化疗表现出p53介导的衰老反应。这种反应在某些肿瘤类型中实际上是有害的,因为衰老细胞可通过持续存在并通过获得性分泌表型产生细胞因子和趋化因子来驱动复发。